News Releases3.18.26
Barnes & Thornburg Advises GNQ Insilico Inc. on $500M De-SPAC IPO Transaction With IB Acquisition Corp.
Barnes & Thornburg is serving as U.S. legal advisor to GNQ Insilico Inc. in its pending business combination with IB Acquisition Corp. (IBAC), a special purpose acquisition company, which will take the AI drug discovery and development company public on Nasdaq.
The transaction values GNQ Insilico at $500 million, with current GNQ shareholders having the ability to earn additional consideration through revenue earnout and share price earnout provisions.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
